Literature DB >> 10400625

c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB.

A Costanzo1, C Guiet, P Vito.   

Abstract

Members of the tumor necrosis factor receptor superfamily induce apoptosis via interaction with FADD and regulate cell growth and differentiation through TRADD and TRAFs molecules. While screening for molecules involved in the regulation of death receptor signaling, we identified a novel protein, c-E10. c-E10 contains an amino-terminal caspase-recruiting domain (CARD) and shares a sequence homologous with E10, a viral CARD-containing protein that binds to c-E10. In transfection experiments c-E10 oligomerizes, binds to the cytoplasmic portion of TRAIL receptor 1 (DR4) and coprecipitates with TRADD. Expression of c-E10 under the control of a doxycycline-dependent transcriptional transactivator results in NF-kappaB activation, which is inhibited by dominant negative forms of TRAF2 and NIK kinase. Thus, our results suggest that c-E10 is an adapter protein that activates NF-kappaB through a molecular pathway involved in death receptor signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400625     DOI: 10.1074/jbc.274.29.20127

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.

Authors:  H Ye; A Dogan; L Karran; T G Willis; L Chen; I Wlodarska; M J Dyer; P G Isaacson; M Q Du
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Molecular basis of lysophosphatidic acid-induced NF-κB activation.

Authors:  Wenjing Sun; Jianhua Yang
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

Review 3.  Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.

Authors:  Margot Thome; Jean Enno Charton; Christiane Pelzer; Stephan Hailfinger
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-04       Impact factor: 10.005

4.  Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan.

Authors:  Sumit Bhattacharyya; Alip Borthakur; Arivarasu N Anbazhagan; Shivani Katyal; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

5.  Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.

Authors:  Miguel E Moreno-García; Karen Sommer; Hector Rincon-Arano; Michelle Brault; Jun Ninomiya-Tsuji; Lydia E Matesic; David J Rawlings
Journal:  Mol Cell Biol       Date:  2013-01-07       Impact factor: 4.272

6.  Bcl10 can promote survival of antigen-stimulated B lymphocytes.

Authors:  Maoxin Tim Tian; Gabriel Gonzalez; Barbara Scheer; Anthony L DeFranco
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

7.  Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.

Authors:  Erika Scharschmidt; Elmar Wegener; Vigo Heissmeyer; Anjana Rao; Daniel Krappmann
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Different evolutionary strategies for the origin of caspase-1 inhibitors.

Authors:  Júlia P C da Cunha; Pedro A F Galante; Sandro J de Souza
Journal:  J Mol Evol       Date:  2008-05-14       Impact factor: 2.395

9.  Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.

Authors:  Mei Yu; Yuhong Chen; Yinghong He; Andrew Podd; Guoping Fu; Jacqueline A Wright; Eden Kleiman; Wasif N Khan; Renren Wen; Demin Wang
Journal:  J Immunol       Date:  2012-10-19       Impact factor: 5.422

10.  Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation.

Authors:  Hu Zeng; Lie Di; Guoping Fu; Yuhong Chen; Xiang Gao; Langlai Xu; Xin Lin; Renren Wen
Journal:  Mol Cell Biol       Date:  2007-05-14       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.